Ardent Health downgraded to Neutral at BofA after Trump win

BofA downgraded Ardent Health (ARDT) to Neutral from Buy with a price target of $19, down from $22. After the election win for Donald Trump, the firm sees risks to exchanges and Medicaid supplemental payments, noting that it views the Trump win as negative for healthcare facilities, and hospitals in particular, and believes that the current favorable environment is at risk.